Control protein synthesis and autophagy through downstream PI3K-Akt-mTOR pathways that are known to be dysregulated in AD and epilepsy (Ma and Blenis, 2009; Ma et al., 2010; Talbot et al., 2012; Nixon, 2013). This evidence concerns the gene AKT1 and Alzheimer disease.